G1 Checkpoint Protein and p53 Abnormalities in Bladder Cancer
Author Information
Author(s): Niehans G A, Kratzke R A, Froberg M K, Aeppli D M, Nguyen P L, Geradts J
Primary Institution: Minneapolis Department of Veterans Affairs Medical Center
Hypothesis
Cyclin D1 and p16INK4a cooperate to dysregulate the cell cycle in bladder carcinomas.
Conclusion
G1 restriction point defects can be identified in the majority of bladder carcinomas.
Supporting Evidence
- Rb protein loss occurred in 29% of cases.
- p16INK4a loss occurred in 19% of cases.
- Cyclin D1 was overexpressed in 27% of carcinomas.
- 63% of tumors showed aberrant accumulation of p53 protein.
- 70% of bladder carcinomas showed abnormalities in G1 checkpoint proteins.
Takeaway
Most bladder cancer cases have problems with important proteins that control cell growth, which can lead to more aggressive disease.
Methodology
Immunohistochemistry was used to examine 79 invasive transitional cell carcinomas for protein expression.
Limitations
The study did not find statistical significance for Rb, p16INK4a, and p53 as prognostic factors.
Participant Demographics
Patients with invasive transitional cell carcinomas treated by cystectomy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website